This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Five Best-Performing Biotech Stocks of 2013 (Some May Surprise You)

4. MannKind (MNKD) ^NBI Chart ^NBI data by YCharts

Cult stocks do well in frothy bull markets, which helps explain MannKind's inclusion on this list. The next round of pivotal clinical trials for the fast-acting inhaled insulin Afrezza are due in August, following two FDA rejections already. With MannKind shares clearly running up in anticipation of the data and the worshipping of company founder Al Mann reaching a zenith, anything less than a stellar performance from Afrezza could hit the stock hard.

4 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
CHTP $0.00 0.00%
ACAD $35.55 -2.80%
CLVS $80.01 -2.40%
CLSN $2.51 -4.90%
KERX $10.17 -3.00%


DOW 17,967.47 -102.93 -0.57%
S&P 500 2,093.27 -21.22 -1.00%
NASDAQ 4,942.8650 -74.0640 -1.48%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs